Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout …

XP Yang, YH Liu, D Mehta, MA Cavasin… - Circulation …, 2001 - Am Heart Assoc
XP Yang, YH Liu, D Mehta, MA Cavasin, E Shesely, J Xu, F Liu, OA Carretero
Circulation research, 2001Am Heart Assoc
Using B2 kinin receptor gene knockout mice (B2−/−), we tested the hypothesis that (l) lack of
B2 receptors may affect blood pressure and cardiac function and aggravate cardiac
remodeling after myocardial infarction (MI), and (2) kinins partially mediate the cardiac
beneficial effect of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II type 1
receptor antagonists (AT1-ant), whereas lack of B2 receptors may diminish this
cardioprotective effect. Chronic heart failure (HF) was induced by MI, which was caused by …
Abstract
—Using B2 kinin receptor gene knockout mice (B2−/−), we tested the hypothesis that (l) lack of B2 receptors may affect blood pressure and cardiac function and aggravate cardiac remodeling after myocardial infarction (MI), and (2) kinins partially mediate the cardiac beneficial effect of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II type 1 receptor antagonists (AT1-ant), whereas lack of B2 receptors may diminish this cardioprotective effect. Chronic heart failure (HF) was induced by MI, which was caused by coronary artery ligation in both B2−/− and 129/SvEvTac mice (wild-type control, B2+/+). An ACEi (ramipril, 2.5 mg/kg/d) or AT1-ant (L-158809, 3 mg/kg/d) was given 1 week after MI and was continued for 12 weeks. Left ventricular (LV) ejection fraction, cardiac output (CO), diastolic LV dimension (LVDd), and LV mass were evaluated by echocardiography. Myocyte cross-sectional area and interstitial collagen fraction were studied histopathologically. We found that basal blood pressure and cardiac function were similar in B2+/+ and B2−/− mice. After MI, development of HF and remodeling were also similar between the 2 strains. The ACEi improved cardiac function and remodeling in both strains; however, its effects were attenuated in B2−/− mice (respective values for B2+/+ versus B2−/− mice: overall increase in ejection fraction, 64±10% versus 21±5% [P<0.01]; increase in CO, 69±17% versus 23±9% [P<0.01]; overall decrease in LVDd, −24±3% versus −7±4% [P<0.01]; and decrease in LV mass, −38±3% versus −6±6% [P<0.01]). AT1-ant had a beneficial cardiac effect similar to that produced by ACEi, and this effect was also diminished in B2−/− mice (respective values for B2+/+ versus B2−/− mice: overall increase in ejection fraction, 46±10% versus 25±9% [P<0.01]; increase in CO, 44±14% versus 15±5% [P<0.01]; overall decrease in LVDd, −14±4% versus −6±3% [P<0.01]; and decrease in LV mass, −33±4 versus −16±7% [P<0.01]). The effect of ACEi or AT1-ant on myocyte cross-sectional area was similar between strains; however, their effect on the interstitial collagen fraction was diminished in B2−/− mice. We concluded that (1) lack of B2 kinin receptors does not affect cardiac phenotype or function, either under normal physiological conditions or during the development of HF; and (2) kinins acting via the B2 receptor play an important role in the cardioprotective effect of ACEi and AT1-ant.
Am Heart Assoc